艾美捷PolyMag CRISPR試劑盒#PNC40200高轉(zhuǎn)染效率無毒性,靈敏性高、特異性強(qiáng),用途范圍廣,具體特色如下:
• 即使在原代細(xì)胞和難以轉(zhuǎn)染的細(xì)胞上也能高效遞送 CRISPR/Cas9 系統(tǒng)• 非常適合共轉(zhuǎn)染 pDNA/pDNA、pDNA/gRNA、pDNA/mRNA
• 針對(duì)含有 Cas9 的大質(zhì)粒 DNA 進(jìn)行了優(yōu)化,并引導(dǎo) RNA
• 低細(xì)胞毒性 - 能夠以更少的細(xì)胞開始實(shí)驗(yàn)
PolyMag CRISPR kit is the only magnet assisted transfection reagent optimized to deliver high level of plasmid DNA and/or mRNA expressing Cas9 and guide RNA (gRNA). This reagent is based on our proprietary Magnetofection™ technology. The nanoparticles are composed of iron oxide magnetic core coated with cationic molecules. For your gene editing experiments, this reagent provides high transfection efficiency without toxicity.
Benefits:
• High efficiency delivery of CRISPR/Cas9 system even on primary and hard to transfect cells
• Ideal for co-transfection of pDNA/pDNA, pDNA/gRNA, pDNA/mRNA
• Optimized for large plasmid DNA containing Cas9, and guide RNA
• Low cell toxicity - enable to start your experiment with less cell
用于CRISPR Cas9實(shí)驗(yàn)的其他產(chǎn)品:
ViroMag CRISPR提高CRISPR/Cas9病毒的轉(zhuǎn)導(dǎo)效率
RmesFect CRISPR 用于 mRNA 轉(zhuǎn)染
ProDeliverIN CRISPR用于 Cas9 蛋白遞送
儲(chǔ)存: +4°C
運(yùn)輸條件:室溫
Figure1 : PolyMag CRISPR co-transfection efficiency for CRISPR-Cas9 experiments. NIH-3t3, HeLa and MDCK cells were plated in 24-well plates in complete medium at the optimum density of 50-70% confluence at the time of transfection. Cells were transfected with a GFP-Cas9 plasmid and a RFP pDNA and then incubated overnight at 37oC. GFP and RFP expression was monitored 24h after transfection by fluorescence microscopy.
相關(guān)產(chǎn)品
免責(zé)聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)和對(duì)其真實(shí)性負(fù)責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品第一來源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。